Elsevier

Neuroscience Letters

Volume 442, Issue 1, 5 September 2008, Pages 54-58
Neuroscience Letters

A SMNΔ7 read-through product confers functionality to the SMNΔ7 protein

https://doi.org/10.1016/j.neulet.2008.06.059Get rights and content

Abstract

Spinal muscular atrophy (SMA) affects about 1 in every 6000 children born and is the leading genetic cause of infant death. SMA is a recessive disorder caused by the mutation or deletion of Survival Motor Neuron-1 (SMN1). SMN2, a nearly identical copy gene, has the potential to encode the same protein as SMN1 and is retained in all SMA patients. The majority of SMN2-derived transcripts are alternatively spliced and therefore encode a truncated isoform lacking exon 7 (SMNΔ7), which is a defective protein because it is unstable, has a reduced ability to self-associate and is unable to efficiently function in SMN cellular activities. However, we have shown that the SMN C-terminus functions non-specifically, since heterologous sequences can compensate for the exon 7 sequence. Several classes of compounds identified in SMN-inducing high throughput screens have been proposed to function through a read-through mechanism; however, a functional analysis of the SMNΔ7 read-through product has not been performed. In this report, the SMNΔ7 read-through product is characterized and compared to the SMNΔ7 protein. In a series of in vitro and cell based assays, SMNΔ7 read-through product is shown to increase protein stability, promote neurite outgrowths in SMN deficient neurons, and significantly elevate SMN-dependent UsnRNP assembly in extracts from SMA patient fibroblasts. Collectively, these results demonstrate that SMNΔ7 read-through product is more active than the SMNΔ7 protein and suggest that SMA therapeutics that specifically induce SMNΔ7 read-through may provide an alternative platform for drug discovery.

Section snippets

Acknowledgements

V.B.M. is supported by the Clinical BioDectives Program (NIH T90 DK070105). This work was funded by grants from Phi Zeta-Pi Chapter Research Grant (V.B.M.), FightSMA (C.L.L.), the Muscular Dystrophy Association (C.L.L.) and the National Institutes of Health (C.L.L, R01 NS41584; R01 HD054413).

References (23)

  • D.D. Coovert et al.

    The survival motor neuron protein in spinal muscular atrophy

    Hum. Mol. Genet.

    (1997)
  • Cited by (33)

    • Spinal muscular atrophy

      2018, Handbook of Clinical Neurology
      Citation Excerpt :

      Given the challenges of blood–brain barrier penetrability facing other current strategies, this series of orally bioavailable compounds presents a promising potential therapy for SMA patients. Another approach to increasing SMN2 expression is through the use of aminoglycosides to force “read through” past the stop codon of the SMNΔ7 transcript, producing an artificially elongated protein product that is comparatively more stable and functional than the SMNΔ7 protein (Mattis et al., 2008). Treatment of cells (Mattis et al., 2006) and mice (Mattis et al., 2009, 2012) with these compounds showed increased SMN protein and improved neuromuscular phenotype.

    • Small Molecule Approaches to Upregulate SMN Expression From the SMN2 Locus

      2017, Spinal Muscular Atrophy: Disease Mechanisms and Therapy
    • Mammalian Models of Spinal Muscular Atrophy

      2017, Spinal Muscular Atrophy: Disease Mechanisms and Therapy
    • Spinal muscular atrophy: An update on therapeutic progress

      2013, Biochimica et Biophysica Acta - Molecular Basis of Disease
    • Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy

      2012, Neuroscience Letters
      Citation Excerpt :

      This could be due to the small increase in gross motor function, seen by the TTR testing, denoting the ability of these severe mice to feed better. It has been shown that SMNΔ7 protein has severely reduced functionality when compared to full-length SMN [1,15], assumedly due mostly to its instability [2] and inability to interact with members of the Gemin complex [2], known to be crucial in SMN's most well-studied role in UsnRNP biogenesis. Therefore, it is completely logical that if SMNΔ7 could regain its stability to self-associate and associate with its complex, it would regain its functionality.

    View all citing articles on Scopus
    View full text